Pura Vida Investments, LLC Incyte Corp Put Options Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2018 Feb 11, 2021	BUY	$83.06 - $100.98 $4.11 Million - $5 Million	49,500 Added 9900.0%	50,000 $4.17 Million
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $4.11 Million - $5 Million	-49,500 Reduced 99.0%	500 $0
Q4 2017 Feb 11, 2021	BUY	$93.56 - $116.6 $4.68 Million - $5.83 Million	50,000 New	50,000 $4.74 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $4.68 Million - $5.83 Million	-50,000 Closed	0 $0
Q3 2017 Nov 17, 2017	SELL	$109.15 - $138.27 $4.69 Million - $5.95 Million	-43,000 Reduced 46.24%	50,000 $1.44 Billion
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $10.2 Million - $12.9 Million	93,000	93,000 $1.58 Billion

666

187M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.